Publication
Stage migration in prostate cancer: the role of PSMA-PET in identifying oligometastatic disease.
Francesco Mattana, Stefano Luzzago, Valentino Dragonetti, Veeru Kasivisvanathan, Sinead Conlon, Paolo Castellucci, Andrea Farolfi, Marcin Miszczyk, Tomasz Techmański, Pawel Rajwa, Shahrokh F Shariat, Fabio Zattoni, Giuseppe Reitano, Alberto Briganti, Francesco Montorsi, Samuele Frassoni, Vincenzo Bagnardi, Giorgio Gandaglia, Francesco Ceci
- Source
- PubMed
- Retrieved
- Sep 30, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260930-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
PURPOSE: Oligometastatic disease (OMD) represents an intermediate disease state between localized and metastatic prostate cancer (PCa), where patients may still benefit from curative treatments. The prevalence of "de novo" metastatic disease detected by positron emission tomography (PET) with…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Prostate Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available